Almac Group
55+ years delivering integrated drug development and manufacturing across 18 global facilities.
Listed on cdmo.directory
Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. Headquartered in Belfast, United Kingdom.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Synthetic chemistry infrastructure
- Capabilities
- HPAPIFlow ChemistryHydrogenation
Fill-finish formats
Regulatory clearances
Services
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Process Development
- CMC Analytical Development
- Formulation Development
- Stability Testing & Storage
- Quality Control Testing
- Flow Chemistry & Continuous Manufacturing
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- Oral Solid Dosage Manufacturing
- Technology Transfer
- CMC Regulatory Submission Support
- Solid-State Chemistry & Polymorph Screening
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Cold-Chain Storage & Logistics
- Small Molecule Development & Manufacturing
- Serialization & Track-and-Trace
- Secondary Packaging & Labeling
- Extractables & Leachables Studies
- Combination Product Assembly & Final Packaging
- Cell-Line Development
- Upstream Processing
- Downstream Processing
About this organization
Almac Group is a contract development and manufacturing organization (CDMO) with over 55 years of experience and a global footprint of 18 facilities. The organization serves top 25 BioPharma companies and has contributed to approximately 50% of approved new molecular entities (NMEs) in the last 6 years.
Core Capabilities:
- Analytical method development and stability testing
- Formulation development and bioavailability enhancement
- Process development and technology transfer
- Small molecule API synthesis and specialized chemistry (flow chemistry, hydrogenation)
- Fill-finish manufacturing across multiple formats
- Cold chain and logistics solutions
- Quality control and CMC regulatory support
Recent Investments & Expansion:
- cGMP flow hydrogenation capability launch (March 2026)
- Enhanced US analytical capacity with new stability chambers in Souderton, PA (August 2025)
- Multi-million-pound investment in cold chain capabilities in Craigavon (July 2025)
- Multi-million-pound investment in Singapore expansion (November 2025)
Almac operates with a commitment to long-term client partnerships and tailored solutions across the drug development lifecycle.
Certifications
| Authority | Identifier | Source |
|---|---|---|
| GMP | GMP | View |
Locations
Headquarters
Belfast · Northern Ireland · United Kingdom
US Operations
Multiple · United States · United States
Partner Lab
Multiple · Asia · Asia
Headquarters / UK
UK · United Kingdom
US
US · United States
Asia Partner Lab
Asia
Headquarters
Craigavon · Northern Ireland · United Kingdom
Souderton
Souderton · Pennsylvania · United States
Singapore
Singapore · Singapore · Singapore
Craigavon
Craigavon · Northern Ireland · United Kingdom
North Carolina
North Carolina · North Carolina · United States
Submit a verified review for this organization.
Markdown mirror: /companies/almacgroup.md